5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.01%
Revenue growth above 1.5x VALMT.HE's 0.34%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
1.21%
Gross profit growth under 50% of VALMT.HE's 2.65%. Michael Burry would be concerned about a severe competitive disadvantage.
5.90%
EBIT growth below 50% of VALMT.HE's 62.50%. Michael Burry would suspect deeper competitive or cost structure issues.
5.90%
Operating income growth under 50% of VALMT.HE's 62.50%. Michael Burry would be concerned about deeper cost or sales issues.
23.81%
Net income growth at 50-75% of VALMT.HE's 45.45%. Martin Whitman would question fundamental disadvantages in expenses or demand.
19.96%
EPS growth under 50% of VALMT.HE's 57.14%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
19.96%
Diluted EPS growth under 50% of VALMT.HE's 57.14%. Michael Burry would worry about an eroding competitive position or excessive dilution.
3.17%
Slight or no buybacks while VALMT.HE is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
3.17%
Slight or no buyback while VALMT.HE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-43.93%
Negative OCF growth while VALMT.HE is at 154.35%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-41.13%
Negative FCF growth while VALMT.HE is at 197.22%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-26.25%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-26.25%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-29.91%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-32.08%
Negative 10Y OCF/share CAGR while VALMT.HE stands at 1435.64%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-32.08%
Negative 5Y OCF/share CAGR while VALMT.HE is at 1435.64%. Joel Greenblatt would question the firm’s operational model or cost structure.
139.50%
3Y OCF/share CAGR under 50% of VALMT.HE's 1435.64%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
124.28%
Positive 10Y CAGR while VALMT.HE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
124.28%
Positive 5Y CAGR while VALMT.HE is negative. John Neff might view this as a strong mid-term relative advantage.
152.97%
Positive short-term CAGR while VALMT.HE is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-22.21%
Negative 3Y equity/share growth while VALMT.HE is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-25.68%
Firm’s AR is declining while VALMT.HE shows 0.23%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-2.01%
Inventory is declining while VALMT.HE stands at 5.83%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.69%
Asset growth at 50-75% of VALMT.HE's 3.81%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
-0.51%
We have a declining book value while VALMT.HE shows 10.80%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
0.26%
We have some new debt while VALMT.HE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-3.01%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.